Bildkälla: Stockfoto

Lime: Healthy pipeline but unhealthy valuation - SEB

Positive revisions on hiked margin assumptions
We cut revenue estimates by 1% for 2020, 2% for 2021 and 3% for 2022 on lower ARR in Q3 but raise our adjusted EBITA estimates by 5%, 4% and 3%, respectively. This stems from our belief that we previously have underestimated scalability given cost coverage from recurring revenues increasing. We now forecast an adjusted EBITA margin of 28% in 2020 and 2021 (mainly stemming from larger recruitment cohorts and a reversal of temporary cost savings in 2020) and 30% in 2022. Lime targets EBITA margins of >23%.

M&A and product pipeline should fill up soon
We think Lime sounded unsurprisingly forward-leaning on the prospects of M&A (either on the tech or the expansion side). This bodes well for future value creation. However, while tech acquisitions typically come with small revenues and high up-selling potential and expansion acquisitions come with larger revenues but a need to integrate and convert customer bases, both involve some lag from acquisition to actual value creation. Encouragingly, Lime has been active on the R&D side with new products including renewals of Lime BI, Lime GO and the launch of e-signing tools. This should improve client acquisition and retention while providing Lime with up-selling opportunities.

Valuation still on the high side
Post these revisions and today’s share price decline, Lime trades at EV/EBITDA of 32x for 2021 and 27x for 2022. Our fair valuation range is SEK 245-264. (SEK 237-255)
Börsvärldens nyhetsbrev
ANNONSER